Position in AEON
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$68
-$25 QoQ
Shares Held
95
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 22 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AEON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $446,515 across 36 Biotechnology names. AEON ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COYA |
Coya Therapeutics, Inc.
|
26,171 | $153,100 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
1,500 | $85,830 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
168 | $83,450 | |
| 4 | 1,201 | $37,747 | |||
| 5 | ABVX |
Abivax S.A.
|
263 | $35,047 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33 | $20,576 | |
| 7 | PBYI |
Puma Biotechnology, Inc.
|
1,170 | $9,488 | |
| 8 | XNCR |
Xencor Inc
|
468 | $7,534 |
All Filings in AEON
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68 | 95 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $93 | 95 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $104 | 95 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $76 | 95 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $18 | 24 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $8 | 15 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $591 | 1,095 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,149 | 1,095 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,149 | 1,095 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $12,702 | 1,095 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $7,884 | 1,095 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $6,132 | 1,095 | Shares | Sole | 2023-10-17 | |
| No filing history on record for this holder in this stock. | ||||||